Evaluating the Clinical Effectiveness of "Endotracheal Tube Position Anomaly Alerting System"

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorKaohsiung Medical University Chung-Ho Memorial Hospital

About this trial

The goal of this clinical trial is to determine whether the Endotracheal Tube Position Anomaly Alerting System (ETPAAS) effectively reduces the duration of endotracheal tube malposition in patients admitted to the intensive care unit (ICU). Additionally, the study will assess the clinical impact, usability, and user satisfaction of ETPAAS.

The main questions it aims to answer are:

* Does ETPAAS reduce the duration of endotracheal tube malposition? * What are healthcare workers' perspectives on the usability and satisfaction of ETPAAS?

Participants will receive standard care, with or without ETPAAS, in the intensive care unit.

Researchers will evaluate the duration of endotracheal tube malposition. Healthcare workers will complete a questionnaire assessing the usability and satisfaction of ETPAAS.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients admitted to the intensive care unit

At least 18 years old

Disqualifiers

Patients disagree to participate in the study

Trial design

Design model

Crossover

Treatments tested in this trial

  • "Endotracheal Tube Position Anomaly Alerting System"

    Other intervention

    The "Endotracheal Tube Position Anomaly Alerting System" (ETPAAS) is designed to assist healthcare providers in managing patients receiving mechanical ventilation via an endotracheal tube. This system integrates an artificial intelligence (AI) algorithm that automatically evaluates the appropriateness of endotracheal tube positioning whenever a patient's chest X-ray is uploaded. If the system detects that the distance between the endotracheal tube tip and the carina falls outside the optimal range, it promptly alerts healthcare providers, enabling timely intervention to correct the tube position and enhance patient safety.

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: ETPAASExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Duration of endotracheal tube malposition

Time frame
from the initial detection of endotracheal tube malposition to its correction, an estimated average of 48 hours

Secondary outcomes

1

Usability and user satisfaction survey with a questionnaire

Time frame
through study completion, up to 6 months
2

Prevalence of endotracheal tube malposition

Prevalence of endotracheal tube malposition on the first chest radiograph on ICU admission and on the second chest radiograph taken in the ICU

Time frame
through study completion, up to 6 months
3

ICU length of stay

Time frame
from ICU admission to ICU discharge, an estimated average of 7 days
4

Duration of mechanical ventilation

Time frame
from intubation to the discontinuation of mechanical ventilation, an estimated average of 5 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: